Skip to main content
Premium Trial:

Request an Annual Quote

Myriad Genetics Develops New Database to Identify Genes in CNS Disorders

Premium

SALT LAKE CITY--Myriad Genetics, a genomics company here, has announced a collaboration with Valley Mental Health that will develop a new database bringing together Myriad's genealogical database with approximately 100,000 anonymous patient records from Valley. The database will be used to identify genes involved in such central nervous system disorders as depression, bipolar disorder, and dementia.

Myriad will receive worldwide exclusive rights to diagnostic and therapeutic applications of data generated by the collaboration. Peter Meldrum, Myriad's president and CEO, called the collaboration "an invaluable resource for ad vancing this CNS gene discovery program."

Filed under

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.